Literature DB >> 23209039

Prevalence of 25(OH) vitamin D insufficiency and deficiency in pediatric patients on chronic dialysis.

Hee Yeon Cho1, Hye Sun Hyun, Hee Gyung Kang, Il Soo Ha, Hae Il Cheong.   

Abstract

BACKGROUND: 25(OH) Vitamin D [25(OH)D] is the major circulating form of vitamin D and the parameter used to reflect vitamin D status. Patients with chronic kidney disease (CKD) are likely to have low levels of 25(OH)D, and recent observations have linked suboptimal vitamin D status with adverse cardiovascular outcomes, inflammation, insulin resistance, and the rate of progression of renal insufficiency. Little is known about the magnitude of vitamin D deficiency in pediatric patients with stage 5 CKD on chronic dialysis.
OBJECTIVES: The aim of the present cross-sectional study was to assess the prevalence of abnormal vitamin D status in children on chronic dialysis.
METHODS: Serum 25(OH)D, 1,25(OH)2 vitamin D [1,25(OH)2D], calcium, phosphorus, and parathyroid hormone (PTH) were evaluated in 59 pediatric patients on chronic dialysis. Weekly renal Kt/V and creatinine clearance (CCr) were evaluated as parameters reflecting residual renal function. In these patients, serum 25(OH)D concentrations less than 10 ng/mL were considered deficiency and concentrations of 10 - 30 ng/mL were considered insufficiency.
RESULTS: Of the 59 pediatric patients (mean age: 14.4 ± 5.1 years), 51 (86.4%) were on peritoneal dialysis (PD), and 8 (13.6%) were on hemodialysis. Vitamin D deficiency was found in 32.2% of the patients (n = 19), and vitamin D insufficiency, in 50.8% (n = 30). Patients with serum 25(OH)D concentrations less than 30 ng/mL were older than those with normal 25(OH)D concentrations (15.4 ± 4.5 years vs 9.2 ± 5.1 years, p = 0.000). Patients with 25(OH) D concentrations less than 30 ng/mL had higher PTH levels than did those with normal 25(OH)D concentrations (349.5 ± 318.3 pg/mL vs 142.5 ± 116.9 pg/mL, p = 0.001). In the univariate analysis, there was no correlation between serum 25(OH)D and serum 1,25(OH)2D (r = 0.242, p = 0.064), calcium (r = 0.108, p = 0.415), phosphorus (r = -0.050, p = 0.706), or body mass index (r = -0.046, p = 0.729). In PD patients, serum 25(OH)D was positively correlated with weekly renal Kt/V (r = 0.385, p = 0.005) and CCr (r = 0.443, p = 0.001). In addition, serum 25(OH)D and serum albumin were positively correlated (r = 0.297, p = 0.035) in the PD patients.
CONCLUSIONS: The present study found a high prevalence of 25(OH)D deficiency and insufficiency in children on chronic dialysis. Serum 25(OH)D was associated with residual renal function in children on PD. Further studies to evaluate the consequences of vitamin D deficiency and the impact of therapeutic interventions are needed in pediatric CKD patients.

Entities:  

Keywords:  25(OH) vitamin D deficiency; Chronic kidney disease; chronic dialysis; residual renal function

Mesh:

Substances:

Year:  2012        PMID: 23209039      PMCID: PMC3707718          DOI: 10.3747/pdi.2011.00246

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  31 in total

1.  Redefining vitamin D insufficiency.

Authors:  A Malabanan; I E Veronikis; M F Holick
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

Review 2.  Vitamin D binding protein (Gc-globulin).

Authors:  N E Cooke; J G Haddad
Journal:  Endocr Rev       Date:  1989-08       Impact factor: 19.871

3.  Urinary and dialysate losses of vitamin D-binding protein in children on chronic peritoneal dialysis.

Authors:  Agnieszka Prytuła; David Wells; Timothy McLean; Filipa Balona; Ambrose Gullett; Craig Knott; Michelle Cantwell; Kimberly Hassen; Sarah Ledermann; Lesley Rees; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2011-11-15       Impact factor: 3.714

Review 4.  Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.

Authors:  Michael F Holick
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

5.  Vitamin D3 and calcium to prevent hip fractures in elderly women.

Authors:  M C Chapuy; M E Arlot; F Duboeuf; J Brun; B Crouzet; S Arnaud; P D Delmas; P J Meunier
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

6.  Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study.

Authors:  Esther A González; Ashutosh Sachdeva; Dana A Oliver; Kevin J Martin
Journal:  Am J Nephrol       Date:  2004-09-22       Impact factor: 3.754

7.  Losses of 1,25- and 24,25-dihydroxycholecalciferol in the peritoneal fluid of patients treated with continuous ambulatory peritoneal dialysis.

Authors:  S Shany; J Rapoport; M Goligorsky; N Yankowitz; I Zuili; C Chaimovitz
Journal:  Nephron       Date:  1984       Impact factor: 2.847

8.  25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands.

Authors:  Ulrika Segersten; Pamela Correa; Martin Hewison; Per Hellman; Henning Dralle; Tobias Carling; Göran Akerström; Gunnar Westin
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

9.  In vivo metabolism of the vitamin D analog, dihydrotachysterol. Evidence for formation of 1 alpha,25- and 1 beta,25-dihydroxy-dihydrotachysterol metabolites and studies of their biological activity.

Authors:  F Qaw; M J Calverley; N J Schroeder; D J Trafford; H L Makin; G Jones
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

10.  Vitamin D and vitamin-D-binding protein kinetics in patients treated with continuous ambulatory peritoneal dialysis (CAPD).

Authors:  P Joffe; J G Heaf
Journal:  Perit Dial Int       Date:  1989       Impact factor: 1.756

View more
  7 in total

Review 1.  The clinical relevance of native vitamin D in pediatric kidney disease.

Authors:  Sushmita Banerjee; Jayati Sengupta; Surupa Basu
Journal:  Pediatr Nephrol       Date:  2022-08-05       Impact factor: 3.651

Review 2.  Effects of vitamin D on parathyroid hormone and clinical outcomes in peritoneal dialysis: a narrative review.

Authors:  Roberto Russo; Marinella Ruospo; Mario Cozzolino; Luca De Nicola; Andrea Icardi; Ernesto Paoletti; Sandro Mazzaferro
Journal:  J Nephrol       Date:  2014-07-11       Impact factor: 3.902

3.  Matrix Metalloproteinase (MMP)-9 Levels in Children on Hemodialysis: Association with MMP-9 C-1562T Gene Polymorphism and Vitamin D Levels.

Authors:  Ashraf Galal; Fatina I Fadel; Enas Mokhtar; Manal F Elshamaa; Eman A Elghoroury; Solaf Kamel; Gamila S M Elsaeed; Eman H Thabet
Journal:  Int J Biomed Sci       Date:  2016-09

4.  Low serum levels of vitamin D are associated with anxiety in children and adolescents with dialysis.

Authors:  Bin Han; Fu-Xiang Zhu; Hai-Feng Yu; Si Liu; Jun-Liang Zhou
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

5.  Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients.

Authors:  Cai-Mei Zheng; Chia-Chao Wu; Chi-Feng Hung; Min-Tser Liao; Jia-Fwu Shyu; Yung-Ho Hsu; Chien-Lin Lu; Yuan-Hung Wang; Jing-Quan Zheng; Tian-Jong Chang; Yuh-Feng Lin; Kuo-Cheng Lu
Journal:  Nutrients       Date:  2018-02-10       Impact factor: 5.717

6.  Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis.

Authors:  Xiaohan You; Ying Zhou; Jianna Zhang; Qiongxiu Zhou; Yanling Shi; Zhen Su; Chaoshen Chen; Rongrong Shao; Ji Zhang
Journal:  BMC Nephrol       Date:  2020-05-18       Impact factor: 2.388

Review 7.  Residual renal function in children treated with chronic peritoneal dialysis.

Authors:  Maria Roszkowska-Blaim; Piotr Skrzypczyk
Journal:  ScientificWorldJournal       Date:  2013-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.